Bisacodyl is not a stool softener, bulk former, or mild osmotic syrup. It is a diphenylmethane derivative engineered to physically stimulate the smooth muscles of the colon. Once the compound reaches the lower bowel, local enzymes break it down into an active metabolite, bis-(p-hydroxyphenyl)-pyridyl-2-methane. This metabolite acts directly on mucosal nerve plexus endings in the colon wall, prompting high-amplitude propagating contractions.
These rhythmic muscular surges, known as peristalsis, forcefully shuttle stagnant fecal matter toward the rectum. Concurrently, bisacodyl alters water and electrolyte flux across the intestinal wall, pulling fluid into the colonic lumen to soften hard stool. Because the oral tablets carry a specialized enteric coating, they survive the highly acidic gastric bath of the stomach and the digestive enzymes of the small intestine intact. Dissolution only begins when the tablet encounters the neutral-to-alkaline pH of the lower ileum and colon, which prevents premature vomiting and upper gastric irritation.
